Skip to content

Clinical trials

Phase 2 Non-ST Elevated Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-ST Elevated Myocardial Infarction Phase: Phase 2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20092
20112
20121
20141
20151
20181
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ablynx, a Sanofi company1
Anthera Pharmaceuticals1
Central South University1
GlaxoSmithKline1
Healios K.K.1
Ischemix, LLC1
Isfahan University of Medical Sciences1
Mayo Clinic1
Oslo University Hospital1
Pharming Technologies B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-ST Elevated Myocardial Infarction12
Angina, Unstable5
Angina, Stable3
Coronary Artery Disease3
Acute Coronary Syndrome2
Cardiovascular Diseases1
Inflammation1
Myocardial Infarction1
Myocardial Ischemia1
Myocardial Reperfusion Injury1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.